Paper35211154
Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis.
Ruan GT and 7 others. Front Genet, 2022. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis. Papers, record 35211154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35211154
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33061426 | The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/33061426 | PubMed |
| 2 | 15187109 | Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. | J Immunol | 2004 | https://conductscience.org/library/papers/15187109 | PubMed |
| 3 | 34335635 | NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis. | Front Immunol | 2021 | https://conductscience.org/library/papers/34335635 | PubMed |
| 4 | 34206705 | Acetyl Coenzyme A Synthase 2 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Cervical Squamous Cell Carcinoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34206705 | PubMed |
| 5 | 12646700 | Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12646700 | PubMed |
| 6 | 21798219 | NKG2D and its ligands: key to immunotherapy of liver cancer? | J Hepatol | 2012 | https://conductscience.org/library/papers/21798219 | PubMed |
| 7 | 31886580 | The diagnosis and prognosis values of WNT mRNA expression in colon adenocarcinoma. | J Cell Biochem | 2020 | https://conductscience.org/library/papers/31886580 | PubMed |
| 8 | 28811958 | Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/28811958 | PubMed |
| 9 | 34252935 | OncoThreads: visualization of large-scale longitudinal cancer molecular data. | Bioinformatics | 2021 | https://conductscience.org/library/papers/34252935 | PubMed |
| 10 | 32133645 | Colorectal cancer statistics, 2020. | CA Cancer J Clin | 2020 | https://conductscience.org/library/papers/32133645 | PubMed |
| 11 | 34307169 | Expression and Clinical Significance of Lactate Dehydrogenase A in Colon Adenocarcinoma. | Front Oncol | 2021 | https://conductscience.org/library/papers/34307169 | PubMed |
| 12 | 28407145 | GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/28407145 | PubMed |
| 13 | 23308050 | Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma. | Neoplasia | 2012 | https://conductscience.org/library/papers/23308050 | PubMed |
| 14 | 10760820 | Increased expression of the transcription factors CCAAT-enhancer binding protein-beta (C/EBBeta) and C/EBzeta (CHOP) correlate with invasiveness of human colorectal cancer. | Int J Cancer | 2000 | https://conductscience.org/library/papers/10760820 | PubMed |
| 15 | 18394936 | NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. | Immunity | 2008 | https://conductscience.org/library/papers/18394936 | PubMed |
| 16 | 25367656 | The cancer genome atlas research network: a sight to behold. | Endocr Pathol | 2014 | https://conductscience.org/library/papers/25367656 | PubMed |
| 17 | 25476837 | Evolutionary and structural annotation of disease-associated mutations in human aminoacyl-tRNA synthetases. | BMC Genomics | 2014 | https://conductscience.org/library/papers/25476837 | PubMed |
| 18 | 11557981 | Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. | Nature | 2001 | https://conductscience.org/library/papers/11557981 | PubMed |
| 19 | 12384702 | Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. | Nature | 2002 | https://conductscience.org/library/papers/12384702 | PubMed |
| 20 | 21941282 | Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/21941282 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42718478 | ULBP1 is a prognostic biomarker associated with immune suppression in breast cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/42718478 | PubMed |
| 42106428 | Unraveling the implications of ULBP1 expression from pan-cancer to head and neck squamous cell carcinoma. | Sci Rep | 2026 | https://conductscience.org/library/papers/42106428 | PubMed |
| 42021878 | [Protein Expression Levels of the DCAF4-MEN1-hTERT Axis in Patients With Colon Adenocarcinoma and Their Relationship With Clinicopathological Characteristics and Prognosis]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2026 | https://conductscience.org/library/papers/42021878 | PubMed |
| 41008630 | AARS1 and AARS2: From Protein Synthesis to Lactylation-Driven Oncogenesis. | Biomolecules | 2025 | https://conductscience.org/library/papers/41008630 | PubMed |
| 39519383 | Comprehensive Analysis and Verification of the Prognostic Significance of Cuproptosis-Related Genes in Colon Adenocarcinoma. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39519383 | PubMed |
| 39492940 | UL16‑binding protein 1 is a significant prognostic and diagnostic marker for breast cancer. | Oncol Lett | 2025 | https://conductscience.org/library/papers/39492940 | PubMed |
| 39340738 | Global Trends of Exosomes Application in Clinical Trials: A Scoping Review. | Stem Cell Rev Rep | 2024 | https://conductscience.org/library/papers/39340738 | PubMed |
| 38331839 | Analysis of differences in intestinal flora associated with different BMI status in colorectal cancer patients. | J Transl Med | 2024 | https://conductscience.org/library/papers/38331839 | PubMed |
| 38027647 | FOXD1 expression-based prognostic model for uveal melanoma. | Heliyon | 2023 | https://conductscience.org/library/papers/38027647 | PubMed |
| 37626965 | The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37626965 | PubMed |
| 36980678 | NKG2D Fine-Tunes the Local Inflammatory Response in Colorectal Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980678 | PubMed |
| 36564533 | Investigation of the effects of the royal jelly on genomic demethylation and tumor suppressor genes in human cancer cells. | Med Oncol | 2022 | https://conductscience.org/library/papers/36564533 | PubMed |
| 36465268 | ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis. | Int J Gen Med | 2022 | https://conductscience.org/library/papers/36465268 | PubMed |
| 35565467 | Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35565467 | PubMed |
Genes38
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35211154
GET https://conductscience.org/api/papers/v1/35211154/references?page=2